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1.1 Introduction 
One of the most prevalent applications of hydrogels is wound management. Thanks to their 
high water content and unique physical properties, hydrogels could potentially resemble biological 
tissues including human skin. (Peppas et al. 2000, Gupta et al. 2010, Caló & Khutoryanskiy 2014, Jones 
et al. 2006) There is active interest in the development of new and advanced hydrogel-based products 
from both an academic and industrial perspective. In fact, hydrogels exhibit many characteristics of the 
‘ideal’ wound dressing.  These include: the capability of maintaining a moist environment at the wound 
site allowing gas exchange (moisture vapour transmission), biocompatibility, fast absorption of wound 
exudate, protection of newly formed or delicate skin and  easy and relatively painless dressing removal. 
(Thomas 1990, Gupta et al. 2010, Vowden & Vowden 2014, Boateng & Catanzano 2015) In this 
Chapter we will provide the reader with an overview of the most recent hydrogel materials designed for 
wound management. 
1.2 Skin Anatomy  
 The skin is considered to be the largest organ in the human body. It is responsible for protecting 
the body from external agents, thermoregulation and balance of water loss. (Nicol, 2005) Three different 
layers can be differentiated within the skin structure (Fig. 1): epidermis, dermis and subcutis (or 
hypodermis). The epidermis is composed of 80% keratinocytes that differentiate and migrate towards 
the surface (this process is called keratinization), resulting in the formation of four different ‘strata’ 
(inwards from the outer skin layer): corneum, granulosum, spinosum and basale. (Keng Wooi Ng 2015, 
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Nicol 2005) The stratum corneum (10-20µm thick) has a peculiar organization in which corneocytes 
(representing the physical barrier) are arranged in the well-known ‘bricks in mortar’ system within the 
lipid matrix; the lipid matrix is composed of ceramides, free-fatty acid and cholesterol. (Michaels et al. 
1975, Menon et al. 2012, van Smeden et al. 2014) This layer is always damaged when a wound occurs. 
It also represents one of the major obstacles in topical drug delivery.(Williams, 2003) 
1.3 Classification of Wounds 
A wound is defined as a disruption of skin integrity, which can be a symptom of a pre-existing 
pathological condition or be caused by mechanical, thermal or chemical damage. (Thomas, 1990) 
Wounds can be classified into two main types, depending on the healing time and response to 
treatments: acute or chronic. (Harper et al., 2014) The correct diagnosis of each wound (by identifying 
the causes and types of tissue present) can greatly influence the choice of treatment and the healing 
outcome. (Trudie, 2015) 
1.3.1 Acute Wounds 
Acute or ‘superficial’ wounds usually heal within a period of three weeks and involve only the 
epidermis and dermis (they are then called ‘superficial’) or they can expand into the subcutaneous layer 
(‘full-thickness’). Abrasions, surgical wounds, burns and lacerations are considered acute wounds. 
(Dreifke et al., 2015) Burns can be further classified into: first-degree (resulting from exposure to 
moderate intensity heat and involving primarly only the epidermis), second-degree (involving a large 
part of the dermis as well) and third-degree or full-thickness burns (the skin is completely damaged). 
(Thomas, 1990) 
1.3.2 Chronic Wounds 
Chronic wounds take a minimum of eight weeks up to many years, in some cases, to heal or 
respond to therapy. They can seriously affect the quality of life of the patient causing mobility 
limitations and sometimes depression. These type of wounds are often caused by vascular, 
haemostaseological or metabolic disorders, as well as inflammatory skin diseases, cancer or infections. 
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(Erfurt-Berge and Renner, 2015) Hospitalization is often required with consequent high costs for the 
healthcare system. For example, approximately 2 percent of health budgets are used for chronic wound 
therapies and care. (Harding et al. 2002, Schreml et al. 2010) 
1.4 The Healing Process 
 Wound healing can be described as a cascade of four different events: haemostasis, 
inflammation, proliferation and maturation. Through this dynamic phenomenon, which requires the 
contribution of several molecules, cells and growth factors, the equilibrium is re-established in the body 
and the wound closes. (Hanna & Giacopelli 1997, Gurtner et al. 2008) Considering the complexity of 
the healing cascade it is very impressive to observe how often everything proceeds without any 
problems. (Harper et al., 2014)  In the case of chronic wounds, the process is  delayed by complications 
such as a secondary infection, and it can take much longer for the wound to heal. (Timmons 2006) For 
instance, when there has been considerable tissue loss, wound closure is not immediately possible 
because the edges are too distant or for the presence of sepsis, in which case the microbial load must be 
managed so that the wound can heal without trapping bacteria inside the body. This represents the so-
called closure by secondary intention, which is different from wound closure by primary intention 
which results from suturing wounds that involve minimal tissue loss, such as surgical incisions. (Harper 
et al., 2014) 
 1.4.1 Haemostasis 
 During haemostasis, uncontrolled blood loss is prevented and vascular integrity is restored. 
After tissue damage, the formation of a localized thrombus is promoted: subendothelial collagen and 
von Willebrand factor (vWF) are exposed on the lower face of the endothelium, stimulating platelet 
adhesion. Plasminogen activator inhibitor is produced, allowing fibrin generation through the 
proteolytic cleavage of fibrinogen by thrombin. Cross-linked fibrin then binds to platelets leading to the 
formation of a clot, which is visible to the naked eye. (Austin 2013, Baum & Arpey 2006) The fibrin 
and platelets are the main components of the clot matrix formed, which represents an indispensable 
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scaffold for all the cells that are recruited to the wound during the first steps of the healing process. 
(Gurtner et al. 2008, Baum & Arpey 2006) 
1.4.2 Inflammation 
In order for the healing process to take place the fibrin clot is destroyed (through a process 
called fibrinolysis), facilitating cell migration to the wound site. Fluid movement to the wound is 
promoted through local vasodilation triggered by growth factors released from platelets, and 
enhancement in the permeability of capillaries in the area. (Baranoski and Ayello, 2004) The 
complement system (which involves a variety of different plasma proteins) is then activated: this 
complicated enzyme- triggered cascade is responsible for opsonization, phagocytosis and ultimately, 
the destruction of bacterial cells. (Charles A Janeway et al., 2001) Chemotactic substances (such as 
chemotaxin) are released attracting polymorphonuclear (PMN) neutrophils and monocytes, which will 
differentiate into macrophages. (Mulder, Magda, Small, N., Botma, Y., Ziady, L., MacKenzie, 2002) 
Neutrophils produce important inflammatory factors such as interleukin-1(IL-1) and tumor necrosis 
factor alpha (TNF-α), and proteases which are able to break down damaged extracellular matrix (ECM) 
components. Macrophages play many roles, including phagocytizing bacteria, as well as producing 
collagenases, elastase, other growth factors and many types of cytokines. Evident symptoms of 
inflammation are: erythema, swelling and an increase of the temperature in the injured area. (Granick 
and Teot, 2012)  
  
 1.4.3 Proliferation 
 This phase is characterized by two events that are crucial for the progress of healing: 
angiogenesis, which is defined as the process of formation of new blood vessels or repairing of pre-
exiting ones allowing blood supply to the site of injury, and the production of new ECM. (Flanagan 
2013, Tonnesen et al. 2000) Formation of capillary buds from vascular endothelial cells is promoted by 
angiogenesis factors, such as vascular endothelial growth factor (VEGF) and fibroblast growth factor-
2 (FGF-2). Fibroblasts migrate to the wound in response to the transforming growth factor-β (TGF-β) 
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which is released from macrophages, proliferate and start the production of collagen fibres and other 
connective tissue proteins. As a result, so-called ‘granulation tissue’ is formed: newly formed blood 
vessels within the ECM appear red and granular. (Huether and McCance, 2013) Myofibroblasts 
(differentiated fibroblasts, similar to smooth muscle cells due to the presence of parallel fibres in their 
cytoplasm) present in the granulation tissue are responsible for wound contraction, which usually starts 
6 to 7 days post-injury. (Hinz et al. 2007, Huether & McCance 2013) The choice of the initial dressing 
in this phase is crucial and it has to consider that any mechanical stress could lead to renewed bleeding, 
special care has to be taken to manage the wound and encourage the best healing outcome. (Davey and 
Ince, 1999) 
1.4.4 Maturation 
The maturation phase usually starts 20 days after the injury in acute wounds and it can last from 
six to 18 months, depending on several factors, such as skin type, age and genetic predisposition of the 
subject. (McCulloch & Kloth 2010, Davey & Ince 1999) The aim of this phase is for the injured skin to 
regain its strength and elasticity. This delicate process is controlled by metalloproteinases (MMPs), 
which are responsible for matrix tissue degradation, and their inhibitors. (Hess, 2008) Approximately 
50% of the tensile strength is already regained by the wound two weeks after re-epithelization. However 
after having some types of wounds,  especially chronic wounds, the repaired tissue may not recover 
completely. (Davey and Ince, 1999) 
1.5 Classification of wound dressings 
The choice of the appropriate dressing is very important and it has to be made in accordance 
with the overall wound management plan specific to each individual. This process is of course directly 
determined by the diagnosis of the wound, which is related to a great extent to the aspect and state of 
the wound bed (colour and tissue types present). (Vowden and Vowden, 2014) Wound dressings can 
be generally classified into: dry and moist products. Dry dressings, such as gauzes, are usually easily 
available, very cheap, indicated for low-exuding wounds and they can strongly adhere to the newly 
formed tissue causing painful removal. (Jones et al., 2006) Moist dressings include different types of 
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materials: transparent films, hydrocolloids, alginates, foams and hydrogels.  Transparent film dressings 
(such as Tegaderm® by 3M Health Care) are made from polyurethane or co-polyester and  are flexible 
with an adhesive backing but are incapable of absorbing wound fluids, therefore they should be used 
on dry non-infected wounds only. (Sood et al., 2014) Hydrocolloids (such as DuoDERM® by 
ConvaTec) are usually composed of two layers: the inner adhesive layer in contact with the wound 
containing pectin, gelatin and/ or sodium carboxymethylcellulose, and the outer polyurethane layer 
impermeable to water. They conform to the wound surface absorbing slight to moderate amounts of 
exudate and they do not require frequent changes (they can be kept in place for a maximum of seven 
days). (Hanna and Giacopelli, 1997) Alginates (such as Kaltostat® by ConvaTec) are derived from the 
calcium and sodium salts of alginic acid formed in Phaeophyceae, brown seaweed. They are made up 
of repeating units of mannuronic and glucuronic acid and the ratio between the two units greatly 
influences their absorptive capacity and their tensile strength. They are suitable for medium to highly 
exuding wounds. (Jones et al., 2006) In the presence of high exudate, foam dressings (such as Allevyn® 
by Smith & Nephew) can be used as well, because they can absorb a large amount of wound fluid within 
their porous structure, the limitations being that the dressing must be changed frequently so that pooling 
and spread of wound fluid does not cause breakdown of the surrounding skin (maceration). They are 
commonly represented by polyurethane or silicon foams. (Murphy and Evans, 2012). Dressings 
containing Hydrofiber® technology (such as AQUACEL® by ConvaTec) are made up of sodium 
carboxymethyl cellulose fibres. The fibres form a gel on contact with wound fluid which conforms well 
to the wound bed. Dressings containing Hydrofiber® technology are suitable for low to medium exudate 
levels and due to their gel-like nature can be easily removed from the wound bed without damaging 
new cells. Hydrogel dressings (which will be explored further in the next section) can be made of natural 
or synthetic cross-linked polymeric networks able to absorb large amounts of biological fluids. Their 
so-called ‘moisture donor effect’ promotes collagenase production accelerating autolytic debridement 
of necrotic wounds. (Stashak et al., 2004) 
 
1.6 Hydrogel-based products for wound care 
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 Although hydrogels are now recognized as an alternative to more conventional wound care 
products, they are not routinely employed and there are few products currently available on the market. 
The high production and final costs may prevent the industry from manufacturing these materials on a 
large scale and healthcare professionals from extensively using them on patients. (Caló & 
Khutoryanskiy 2014, Sood et al. 2014) Hydrogel-based products for wound care are usually designed 
as flat transparent sheets, which are very useful for instance in the treatment of pressure wounds, or as 
amorphous gels, which can be applied to wounds at difficult anatomical locations such as cavity wounds 
(acting as fillers) (Figs. 2 and 3). (Jones and Vaughan, 2005) However, independently from the shape 
or design, all hydrogel products must exhibit specific characteristics, such as very high absorption 
capacity, moisture donation capability, transparency, good mechanical properties and  biocompatibility 
in order to have the best performance. (Holbock, Y, Yeao Y., 2011) 
 
 1.6.1 Commercially available hydrogels 
 The wound management industry has experienced a period of incredible development in the 
last decades, continuously designing more advanced technologies and products.(Schreml et al., 2010)  
Since Winter (1962) established that a moist environment effectively helps and accelerates wound 
healing, moist wound dressings, such as hydrogels, started gaining popularity over gauze and dry 
materials.(Jones 2005, Jones & Vaughan 2005, Jones et al. 2006) Whilst bearing in mind that the 
‘perfect’ dressing for every type of wound and every stage of healing would be very difficult to create, 
efforts have been made to manufacture new products with specific features (such as particular designs 
for an easier application or active ingredients added) and keeping the final prices as low as possible. 
(Jones et al. 2006, Leaper 2006) We will mention a few in order to give the reader an idea of the range 
of hydrogel-based products for wound care now available on the market.  
Granugel® (ConvaTec) is an amorphous clear hydrogel containing pectin, carboxymethyl cellulose and 
propylene glycol. It is indicated for the management of partial and full-thickness wound (such as leg 
and pressure ulcers). (Williams, 1996) Intrasite® Gel (Smith & Nephew) is made from modified 
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carboxymethyl cellulose and propylene glycol and it is used for surgical wounds, venous ulcers, diabetic 
foot and pressure ulcers. It is relatively simple to apply thanks to an applicator (Applipak system) and 
is available in different sizes. (Williams 1994, Vernon 2000, Eaglstein 2001) Purilon® Gel (Coloplast) 
also has an applicator, and it is composed of sodium carboxymethyl cellulose, calcium alginate and 
water. It is usually used in conjunction with a secondary dressing, on dry and necrotic wounds. (Caló 
and Khutoryanskiy, 2014) AquaformTM (Aspen Medical), more specifically its newer version, contains 
glycerol, starch copolymer, methylparaben and imidazolidyl urea (as preservatives) and purified water. 
It can be used on flat and cavity wounds with low or no exudate. (Timmons et al., 2008) Aquaflo® 
(Covidien) is a flat hydrogel dressing and is produced from polyethylene glycol and propylene glycol. 
It has a unique disc shape and is transparent to aid monitoring of the wound. First Water Ltd., which 
was recently acquired by Scapa Group plc, manufactures Woundtab®, a flat hydrogel containing 
carboxymethylcellulose, sulphonated copolymer, glycerol and water indicated for chronic wounds. 
(Caló and Khutoryanskiy, 2014) Another well-known hydrogel composition is a KikgelTM developed 
by Rosiak et al., which is made from the combination of a natural polymer (such as agar) and a synthetic 
one (such as poly vinyl pyrrolidone) crosslinked by gamma radiation (Rosiak 1995, Dabbagh et al. 
2010), this dressing is intended for chronic ulcers and burns. Nu-Gel® (Systagenix) is a hydrogel 
dressing made of polyvinyl pyrrolidone and water, indicated for dry, partial and full-thickness wounds. 
(Ovington 2007, Eaglstein 2001)  
Hydrogel wound care products now often contain active ingredients such as antimicrobial agents in 
order to prevent bacteria colonization of the wound and infections that would delay healing.(Leaper, 
2006) For instance, colloidal or ionic silver has been proposed in several wound care products as an 
efficient antimicrobial to be used against pathogens such as Pseudomonas aeruginosa and 
Staphylococcus aureus. (Foster 1996, Seth et al. 2012) Silvasorb® (Medline) is a polyacrylate gel 
produced using the MicroLatticeTM technology, containing ionic silver. It is suitable for chronic deep 
wounds with moderate drainage and can be changed every 3 (amorphous form) to 7 days (gel sheets). 
(Hess 2008, Ovington 2007) Povidone-iodine loaded hydrogel dressings became very popular as well, 
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such as VigilonTM (Bard, distributed by Seton Healthcare Group plc), and are claimed to inhibit bacteria 
growth and proliferation at the wound site. (Mertz et al., 1986)  
 1.6.2 Future hydrogel technologies 
Academia is the cradle of new ideas and exciting findings par excellence, which has always inspired 
industry. Many research projects for the development of advanced wound care technologies have been 
successful  resulting from productive collaborations between academia and industry, and have led to 
significant progress in the field. (Salcido, 1999) From simple dressings, hydrogels become systems for 
the delivery of agents that can accelerate the healing process and actually make a big difference to the 
condition of patients. Gong et al. (Gong et al., 2013) proposed a thermosensitive in-situ forming 
hydrogel containing curcumin loaded micelles, which reported very good in vitro wound healing 
activity. The composite made of poly(ethylene glycol)-poly(ɛ-caprolactone)-poly(ethylene glycol) 
(PEG-PCL-PEG), would gel at body temperature adhering to the tissue and offering a sustained release 
of curcumin over a period of 14 days. Curcumin (extracted from the rhizome of Curcuma longa) has 
been used as a traditional medicine in Southeast Asia for its anti-oxidant, anti-bacterial and anti-
inflammatory activities. However, it has poor solubility in water and oral bioavailability, problems that 
have been bypassed using this system. (Gong et al., 2013) Miguel et al. (Miguel et al., 2014) presented 
an in-situ thermoresponsive and antimicrobial chitosan-agarose hydrogel that accelerates skin 
regeneration. In vitro (using human dermal fibroblasts), and in vivo (using Wistar rats) testing reported, 
shows that this material is able to allow cell migration and proliferation, and to enhance autolytic 
debridement, promoting re-epithelization. Patients with burns can present particularly unpleasant 
scarring and may benefit from  formulations such as this. (Miguel et al., 2014) Burns can also have 
prolonged recovering (up to 10 weeks) especially when the dermis is compromised (full and partial-
thickness burns). Loo et al. (Loo et al., 2014) designed a very interesting hydrogel, formed from 
ultrashort peptides (motif composed of three to seven aliphatic amino acids) in a nanofibrous network, 
that can be used as a primary dressing for these types of burn injuries. These peptides undergo self-
assembly in aqueous conditions and can retain up to 99.9% of water, as the peptides convert into 
hydrogels, they are able to keep the wound hydrated and can be removed easily. The resemblance of 
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the network formed with the ECM facilitates cell adhesion and tissue regeneration, resulting in a faster 
healing when compared with the standard dressing.(Loo et al., 2014) Reyes-Ortega et al. (Reyes-Ortega 
et al., 2015) loaded a gelatin/hyaluronic acid hydrogel with proadrenomedullin N-terminal 20 peptide 
(PAMP). This peptide naturally occurs in the skin and it is known for its proangiogenic, anti-
inflammatory and antibacterial activities. The system presented in this work  is composed of two 
different sections, both bio-functionalized. The external layer is made of polyurethane and loaded with 
bioresorbable nanoparticles containing bemiparin (low molecular weight form of heparin able to 
complex with growth factors such as FGF and VEGF enhancing their activity). The internal layer is 
represented by the biodegradable hydrogel releasing PAMP to the wound. This dressing has been 
proposed for the compromised wounds, such as diabetic ulcers, or in the presence of problematic 
epidermal regeneration, as in the elderly. (Reyes-Ortega et al., 2015) One of the most popular strategies 
to speed up healing is indeed the delivery of peptides, polysaccharides and other molecules that 
naturally take part in this process. For instance, hyaluronic acid (HA), present in the aforementioned 
work as well, has been extensively explored for the role that it plays in the early stages, promoting 
keratinocytes proliferation and migration. Catanzano et al. (Catanzano et al., 2015) developed a 
hydrogel dressing made of alginate (ALG) and HA by internal gelation, the technique that involves the 
slow release of calcium ions which can form complexes with ALG leading to the formation of an 
ionically cross-linked homogenous network without the addition of any toxic cross-linking agents. 
Here, the presence of HA was shown to significantly reduce the time to wound closure as demonstrated 
by the in vivo excision wound model carried out on rats. (Catanzano et al., 2015) Researchers are also 
considering natural molecules extractable from different sources such as bacteria and insects. A good 
example is the work presented by Shi et al. (Shi et al., 2015) that combined poly(γ-glutamic acid) (γ-
PGA, polyamino acid secreted by some Bacilli) and silk sericin (SS, protein obtained from silkworm 
Bombyx mori) to produce an antibacterial hydrogel dressing. (Shi et al., 2015)  Chitosan-based hydrogel 
products have been widely investigated because of chitosan’s intrinsic activity against bacteria and 
fungi, and of course due to the biocompatibility of this polymer, but no products are known to have 
been commercialized yet. (Paul & Sharma 2004, Sparkes et al 1986) 
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When the wound is microscopic in size or affects particularly delicate organs of the body such as the 
eyes, treatment can be very challenging. Tsai et al. (Tsai et al., 2016) proposed a thermosensitive 
chitosan/gelatine/glycerophosphate hydrogel for the delivery of ferulic acid (FA) to corneal burns that 
may be caused by chemicals or ultraviolet-B light exposure. In this condition, an abnormal production 
of reactive oxygen species (ROS) is often observed, and it can be very hard for the endogenous anti-
oxidant system to manage this high level. FA is a polyphenol, natural anti-oxidant compound that can 
prevent ROS damages. However, it has low bioavailability and residence time when administered 
topically in the eye. Its inclusion in the hydrogel system presented by Tsai et al. allows its successful 
sustained release to the cornea with very interesting clinically relevant results in vitro and in vivo. (Tsai 
et al., 2016)  
1.7 Conclusions 
 Hydrogels represent an excellent choice of treatment for many types of wounds, which can be 
difficult to manage with traditional dry dressings. However, patients would benefit from more 
advanced, efficient, cost-effective hydrogel products in order to significantly enhance healing time and 
quality. For these reasons, it is important that industry and academia continue to join their efforts and 
expertise. In future, it is hoped that specific novel computer technologies and equipment will enable the 
development of improved wound management techniques. For instance, new wound image evaluation 
systems such as the one proposed by Veredas et al. (Veredas et al., 2015) could give healthcare 
professionals a great help establishing the correct diagnosis in the shortest possible time. (Veredas et 
al. 2015, Engel et al. 2011) The healthcare system, which annually sustains huge costs for the treatment 
of chronic wounds (of non-hospitalized and hospitalized patients), would greatly benefit, from 
innovative low-cost hydrogel-based wound care solutions for routine use. (Ramos et al. 2015, Sen et al. 
2009)  
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